Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management.

In this review, we describe the epidemiology and clinical significance of resistance in Candida spp. and other non-Cryptococcus yeasts.

The rise in echinocandin resistance, azole resistance and cross-resistance to two or more antifungal classes [multidrug resistance (MDR)] has been a worrisome trend, mainly in US large tertiary and oncology centres, particularly as it relates to Candida glabrata. Candida kefyr is also a concern as it can be resistant to echinocandins and polyenes, especially in patients with haematological malignancies.

Lately, Candida auris has drawn a lot of attention: this uncommon Candida spp. is the first globally emerging fungal pathogen that exhibits MDR and strong potential for nosocomial transmission. Its almost simultaneous spread in four continents could be indicative of increasing selection pressures from the use of antifungal agents. Echinocandin non-susceptibility is also common among non-Candida, non-Cryptococcus yeasts.

rHu IL-2 (cGMP) Solution Pre-filled Syringe 22MIU
AR1001-0022 1mL Ask for price

rHu IL-2 (cGMP) 22MIU
AR1002-0022 22MIU Ask for price

IgG1 Isotype Control Fc fusion protein (biotin)
35R-0022 100 ug
EUR 208
Description: Rat monoclonal IgG1 Isotype Control Fc fusion protein (biotin)

Human complement factor D,CFD ELISA Kit
201-12-0320 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

ELISA kit for PGI2 (Prostacyclin)
E-EL-0022 1 plate of 96 wells
EUR 377
Description: A competitive ELISA kit for quantitative measurement of PGI2 (Prostacyclin) in samples from Serum, Plasma, Cell supernatant

Fast-Pfu with 10mM dNTP Mix (250U)
9K-001-0022 250U
EUR 402.35

2X Pfu PCR Premix (5 x 1mL)
9K-002-0022 5X1mL, 5ml
EUR 581.14

Human thyroxine,T4 ELISA Kit
201-12-0022 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

As Candida resistance patterns reflect, in part, institutional practices of antifungal administration, the benefits of antifungal stewardship protocols are increasingly recognised and endorsed in recent guidelines. Development of rapid diagnostic methods for detecting or ruling out the presence of candidaemia and antifungal resistance, as well as discovery of novel antifungals, are key priorities in medical mycologyresearch.